Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares shot up 1.8% during trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74. The stock has a market capitalization of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The stock has a 50 day moving average of C$0.58 and a 200 day moving average of C$0.58.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Read More
- Five stocks we like better than Acasti Pharma
- What Are Dividend Contenders? Investing in Dividend Contenders
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Energy and Oil Stocks Explained
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is an Earnings Surprise?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
